Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Bach

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The American Journal of Gastroenterology|April 22, 2005
Evaluation of fatigue in U.S. patients with primary biliary cirrhosisCarmen M Stanca, Nancy Bach, Cynthia Krause, et al.
The American Journal of Gastroenterology|August 28, 2004
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALTIra M Jacobson, Furqaan Ahmed, Mark W Russo, et al.
World Journal of Gastroenterology|June 3, 2015
Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virusKieron B L Lim, Hamid R Sima, M Isabel Fiel, et al.
World Journal of Gastroenterology|March 15, 2016
Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virusNeal Patel, Kian Bichoupan, Lawrence Ku, et al.
World Journal of Virology|November 18, 2017
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial resultsKian Bichoupan, Neeta Tandon, James F Crismale, et al.
Frontiers in Immunology|April 16, 2014
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosisCarlo Selmi, Francesca Cavaciocchi, Ana Lleo, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The American Journal of Gastroenterology|April 22, 2005
Evaluation of fatigue in U.S. patients with primary biliary cirrhosisCarmen M Stanca, Nancy Bach, Cynthia Krause, et al.
The American Journal of Gastroenterology|August 28, 2004
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALTIra M Jacobson, Furqaan Ahmed, Mark W Russo, et al.
World Journal of Gastroenterology|June 3, 2015
Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virusKieron B L Lim, Hamid R Sima, M Isabel Fiel, et al.
World Journal of Gastroenterology|March 15, 2016
Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virusNeal Patel, Kian Bichoupan, Lawrence Ku, et al.
World Journal of Virology|November 18, 2017
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial resultsKian Bichoupan, Neeta Tandon, James F Crismale, et al.
Frontiers in Immunology|April 16, 2014
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosisCarlo Selmi, Francesca Cavaciocchi, Ana Lleo, et al.
Pageof 2